Synopsis of recent research by authors named "Carmen Deveau"
- Recent research by Carmen Deveau explores the efficacy and safety of various treatments for COVID-19, including the Phase 3 BLAZE-1 trial assessing bamlanivimab and etesevimab in response to evolving viral variants, highlighting the challenges posed by resistance to these therapies.
- Deveau's work also emphasizes the role of tau pathology as a potential diagnostic tool in Alzheimer's disease, suggesting that monitoring tau alongside amyloid accumulation could improve early diagnosis and intervention strategies.
- Additionally, her investigations into addiction treatments reveal promising findings regarding the use of roflumilast during periods of abstinence from methamphetamine, suggesting potential pathways for pharmacological intervention in stimulant use disorders.